Bristol Myers Squibb Company
About
We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Medical Information aims to empower the healthcare community to make informed decisions about our medicines, enabling better outcomes for patients.
466-GB-2400011 03/2024
Address
Bristol Myers Squibb Pharmaceuticals Limited
ARC Uxbridge Sanderson Road
New Denham, Denham Buckinghamshire
London, England UB8 1DH, GB
Contact details
Medical Information phone number
+44-(0)0800 731 1736
Hours of operation
Available 24 hours a day, 365 days a year
Medical Information website
https://www.bmsmedinfo.co.uk/
Medical Information email
medical.information@bms.com
Click to chat
https://www.bmsmedinfo.co.uk/
Adverse events and product complaints
+44-(0)0800 731 1736
Adverse event phone number
+44-(0)0800 731 1736
Adverse event email
medical.information@bms.com
Company website
https://www.bms.com/gb
BMS products
Medicinal products marked with▼are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
ABRAXANE®
(nab-paclitaxel)
ADCORTYL® Intra-Articular/Intradermal Injection
(triamcinolone acetonide)
AZACTAM®
(aztreonam)
BARACLUDE®
(entecavir monohydrate)
CAMZYOS ▼
(mavacamten)
ELIQUIS® (Co-Promoted Pfizer)
(apixiban)
EMPLICITI®
(elotuzumab)
EVOTAZ®
(atazanavir sulphate, cobicistat)
IMNOVID® ▼
(pomalidomide)
INREBIC® ▼
(fedratinib)
KENALOG®
(triamcinolone acetonide)
NULOJIX®
(belatacept)
ONUREG®
(azacitidine tablets)
OPDIVO® ▼
(nivolumab)
OPDIVO® + YERVOY® Regimen ▼
(nivolumab, ipilimumab)
OPDUALAG® ▼
(nivolumab, relatlimab)
ORENCIA®
(abatacept)
REVLIMID® ▼
(lenalidomide)
SOTYKTU ▼
(deucravacitinib)
SPRYCEL®
(dasatinib)
THALIDOMIDE BMS®
(thalidomide)
VIDAZA®
(azacitidine)
YERVOY®
(ipilimumab)
ZEPOSIA® ▼
(ozanimod)
